UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United States

Haematologica (Roma), 2023-04, Vol.108 (4), p.1190

2023

Volltextzugriff (PDF)

Prospective randomized study correlating intra-operative urethral mucosal injury with early period after transurethral resection of the prostate stricture urethra: A novel concept

Asian Journal of Urology, 2024-07, Vol.11 (3), p.466-472

2024

Volltextzugriff (PDF)

Profile of Arteriovenous Fistula Surgery in Patients with Chronic Kidney Disease at a Tertiary Care Urology Hospital Karnataka, India: A Prospective Interventional Study

Journal of clinical and diagnostic research, 2023-03, Vol.17 (3), p.PC01-PC04

2023

Volltextzugriff (PDF)

Optimization of advanced manufacturing processes using socio inspired cohort intelligence algorithm

International journal for simulation and multidisciplinary design optimization, 2022, Vol.13, p.6

2022

Volltextzugriff (PDF)

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

Frontiers in oncology, 2024-07, Vol.14, p.1407003

2024

Volltextzugriff (PDF)

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

PLoS medicine, 2023-06, Vol.20 (6), p.e1004157-e1004157

2023

Volltextzugriff (PDF)

Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma

Clinical lymphoma, myeloma and leukemia, 2018-07, Vol.18 (7), p.447-451

2018

Volltextzugriff (PDF)

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis

PloS one, 2017-03, Vol.12 (3), p.e0172996

2017

Volltextzugriff (PDF)

Targeting Biology in Non-Hodgkin Lymphoma

Hematology/oncology clinics of North America, 2019-08, Vol.33 (4), p.727-738

2019

Volltextzugriff (PDF)

A phase 1 first‐in‐human study of GS‐0189, an anti‐signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non‐Hodgkin lymphoma (NHL)

EJHaem, 2023-05, Vol.4 (2), p.370-380

2023

Volltextzugriff (PDF)

Characteristics of Patients with Observation As Initial Treatment Strategy in Mantle Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.9358-9360

2022

Volltextzugriff (PDF)

Thrombocytopenia As a Risk Factor for Developing Febrile Neutropenia in Patients with DLBCL Receiving R-CHOP Chemotherapy

Blood, 2022-11, Vol.140 (Supplement 1), p.12122-12124

2022

Volltextzugriff (PDF)

Analytical Modeling and Experimental Study on Machining of CFRP/Ti Stacks with Submerged Abrasive Waterjet Machining

Procedia manufacturing, 2019, Vol.34, p.328-334

2019

Volltextzugriff (PDF)

Spectrum of Second Primary Malignancies and Cause-Specific Mortality Among Patients with Hairy Cell Leukemia in the United States: A Population-Based Study

Blood, 2021-11, Vol.138 (Supplement 1), p.2437-2437

2021

Volltextzugriff (PDF)

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Stage III/IV Classic Hodgkin Lymphoma Treated with Frontline ABVD: A Retrospective Analysis Using a Real-World Database

Blood, 2022-11, Vol.140 (Supplement 1), p.8054-8055

2022

Volltextzugriff (PDF)

Economic Burden of Hematopoietic Cell Transplantation (HCT) Among Commercially Insured Patients with Hematological Malignancies in the United States (US)

Blood, 2022-11, Vol.140 (Supplement 1), p.10798-10800

2022

Volltextzugriff (PDF)

Tafasitamab (TAFA) Plus Lenalidomide (LEN) Prior to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Case Series of 8 Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.12089-12091

2022

Volltextzugriff (PDF)

Copanlisib in the treatment of non-Hodgkin lymphoma

Future oncology (London, England), 2020-09, Vol.16 (26), p.1947-1955

2020

Volltextzugriff (PDF)

Primary effusion lymphoma: current perspectives

OncoTargets and therapy, 2018-01, Vol.11, p.3747-3754

2018

Volltextzugriff (PDF)

Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)

Blood, 2018-11, Vol.132 (Supplement 1), p.1720-1720

2018

Volltextzugriff (PDF)

Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19545-e19545

2021

Volltextzugriff (PDF)

Clinical Features, Treatments and Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma: A Single-Center Experience

Blood, 2020-11, Vol.136 (Supplement 1), p.20-20

2020

Volltextzugriff (PDF)

Evaluating Real-World Treatment Patterns and Outcomes of Mantle Cell Lymphoma

Blood advances, 2022-07, Vol.6 (14), p.4122-4131

2022

Volltextzugriff (PDF)

Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States

Clinical lymphoma, myeloma and leukemia, 2023-07, Vol.23 (7), p.527-534

2023

Volltextzugriff (PDF)

Myosteatosis As a Predictor of Toxicity Among Older Adults with DLBCL Receiving CHOP-Based Regimens

Blood, 2022-11, Vol.140 (Supplement 1), p.3779-3780

2022

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Hematology
(13)
Humans
(9)
Oncology
(9)
Adult
(4)
Care And Treatment
(4)
Patients
(4)
Aged
(3)
Analysis
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Drug Dosages
(3)
Female
(3)
General & Internal Medicine
(3)
Health Aspects
(3)
Kinases
(3)
Male
(3)
Medicine, General & Internal
(3)
Middle Aged
(3)
Treatment Outcome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United States

Prospective randomized study correlating intra-operative urethral mucosal injury with early period after transurethral resection of the prostate stricture urethra: A novel concept

Profile of Arteriovenous Fistula Surgery in Patients with Chronic Kidney Disease at a Tertiary Care Urology Hospital Karnataka, India: A Prospective Interventional Study

Optimization of advanced manufacturing processes using socio inspired cohort intelligence algorithm

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study

Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis

Targeting Biology in Non-Hodgkin Lymphoma

A phase 1 first‐in‐human study of GS‐0189, an anti‐signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non‐Hodgkin lymphoma (NHL)

Characteristics of Patients with Observation As Initial Treatment Strategy in Mantle Cell Lymphoma

Thrombocytopenia As a Risk Factor for Developing Febrile Neutropenia in Patients with DLBCL Receiving R-CHOP Chemotherapy

Analytical Modeling and Experimental Study on Machining of CFRP/Ti Stacks with Submerged Abrasive Waterjet Machining

Spectrum of Second Primary Malignancies and Cause-Specific Mortality Among Patients with Hairy Cell Leukemia in the United States: A Population-Based Study

Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Stage III/IV Classic Hodgkin Lymphoma Treated with Frontline ABVD: A Retrospective Analysis Using a Real-World Database

Economic Burden of Hematopoietic Cell Transplantation (HCT) Among Commercially Insured Patients with Hematological Malignancies in the United States (US)

Tafasitamab (TAFA) Plus Lenalidomide (LEN) Prior to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Case Series of 8 Patients

Copanlisib in the treatment of non-Hodgkin lymphoma

Primary effusion lymphoma: current perspectives

Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)

Safety of same day HD-MTX with induction therapy for DLBCL with concurrent CNS disease or as prophylaxis for high risk of CNS relapse

Clinical Features, Treatments and Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma: A Single-Center Experience

Evaluating Real-World Treatment Patterns and Outcomes of Mantle Cell Lymphoma

Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States

Myosteatosis As a Predictor of Toxicity Among Older Adults with DLBCL Receiving CHOP-Based Regimens

Suchergebnisse filtern